Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial

Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial

Purpose: To report the results of the Single Fraction Early Prostate Irradiation (SiFEPI) phase 2 prospective trial. Materials/Methods: The SiFEPI trial (NCT02104362) evaluated a single fraction of high-dose rate brachytherapy (HDB) for low- (LR) and favorable-intermediate (FIR) risk prostate cancer...

Full description

Bibliographic Details
Main Authors: Jean-Michel Hannoun-Levi, Marie-Eve Chand-Fouche, Tanguy Pace-Loscos, Mathieu Gautier, Jocelyn Gal, Renaud Schiappa, Nina Pujol
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Prostate cancer
High dose rate
Brachytherapy
Single fraction
Cost-effectivness
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630822000696

Internet

http://www.sciencedirect.com/science/article/pii/S2405630822000696

Similar Items